Seer Inc Cl A (SEER)

Feb 27, 2025, 10:09 PM EST - 7 weeks ago

Seer, Inc. (SEER) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 4:05 PM EST - 7 weeks ago

Seer Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Outlook

Feb 21, 2025, 7:00 AM EST - 2 months ago

Seer to Participate in the TD Cowen 45th Annual Health Care Conference

Feb 20, 2025, 7:00 AM EST - 2 months ago

Seer to Feature Proteomic Advancements in Cancer and RNA Therapy Research among other Findings at US HUPO 2025

Feb 13, 2025, 4:15 PM EST - 2 months ago

Seer to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

Jan 2, 2025, 4:05 PM EST - 3 months ago

Seer to Present at the J.P. Morgan 43rd Annual Healthcare Conference

Nov 21, 2024, 4:05 PM EST - 5 months ago

Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

Nov 8, 2024, 7:00 AM EST - 5 months ago

Seer to Participate in Upcoming November Investor Conferences

Nov 6, 2024, 9:00 PM EST - 5 months ago

Seer, Inc. (SEER) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 4:03 PM EST - 5 months ago

Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific

Oct 31, 2024, 7:00 AM EDT - 6 months ago

Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer's, Lung Cancer, and More at ASHG 2024

Oct 21, 2024, 7:00 AM EDT - 6 months ago

Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer's, Population Health, and Xenotransplantation at HUPO 2024

Aug 22, 2024, 4:05 PM EDT - 8 months ago

Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 14, 2024, 4:05 PM EDT - 8 months ago

Seer Appoints Nicolas Roelofs to its Board of Directors

Aug 9, 2024, 7:00 AM EDT - 9 months ago

Seer to Participate in the Canaccord Genuity 44th Annual Growth Conference

Jul 18, 2024, 4:03 PM EDT - 9 months ago

Seer to Report Second Quarter 2024 Financial Results on August 8, 2024

Jun 11, 2024, 11:11 AM EDT - 11 months ago

Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery

Jun 2, 2024, 10:55 AM EDT - 11 months ago

Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ's Early Cancer Detection Study

May 23, 2024, 9:17 AM EDT - 11 months ago

Lab Instrument Industry Update - New Commercial Entrants

AKYA BNGO CTKB DHR LAB MASS OMIC

May 8, 2024, 4:05 PM EDT - 1 year ago

Seer Reports First Quarter 2024 Financial Results

May 8, 2024, 4:03 PM EDT - 1 year ago

Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions

Apr 23, 2024, 4:05 PM EDT - 1 year ago

Seer to Report First Quarter 2024 Financial Results on May 8, 2024

Mar 1, 2024, 7:12 AM EST - 1 year ago

Seer, Inc. (SEER) Q4 2023 Earnings Call Transcript

Feb 29, 2024, 4:05 PM EST - 1 year ago

Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook

Feb 21, 2024, 4:05 PM EST - 1 year ago

Seer to Participate in the TD Cowen 44th Annual Health Care Conference

Feb 6, 2024, 8:00 AM EST - 1 year ago

Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery

Feb 1, 2024, 4:05 PM EST - 1 year ago

Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024

Dec 21, 2023, 4:05 PM EST - 1 year ago

Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference

Nov 10, 2023, 9:00 AM EST - 1 year ago

Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum

Nov 8, 2023, 9:00 AM EST - 1 year ago

Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500

Nov 7, 2023, 10:31 PM EST - 1 year ago

Seer, Inc. (SEER) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 4:05 PM EST - 1 year ago

Seer Reports Third Quarter 2023 Financial Results

Nov 1, 2023, 9:00 AM EDT - 1 year ago

Seer Announces Addition of Panome Bio to Centers of Excellence (COE) Program

Oct 19, 2023, 4:05 PM EDT - 1 year ago

Seer to Report Third Quarter 2023 Financial Results on November 7, 2023

Sep 8, 2023, 4:05 PM EDT - 1 year ago

Seer to Participate in Upcoming September Investor Conferences

Aug 8, 2023, 4:05 PM EDT - 1 year ago

Seer Reports Second Quarter 2023 Financial Results

Jul 27, 2023, 4:05 PM EDT - 1 year ago

Seer to Present at the Canaccord Genuity 43rd Annual Growth Conference

Jul 13, 2023, 4:05 PM EDT - 1 year ago

Seer to Report Second Quarter 2023 Financial Results on August 8, 2023

Jun 7, 2023, 9:00 AM EDT - 2 years ago

Seer Collaborates to Make Scalable, Unbiased Proteomics Accessible to More Researchers via new Seer Technology Access Center

Jun 1, 2023, 9:00 AM EDT - 2 years ago

Seer Launches the Proteograph XT Assay Kit: Allowing Labs to Easily Expand Their View of the Proteome and Scale Their Studies

May 13, 2023, 6:38 PM EDT - 2 years ago

Seer, Inc. (SEER) Q1 2023 Earnings Call Transcript

May 9, 2023, 4:05 PM EDT - 2 years ago

Seer Reports First Quarter 2023 Financial Results

Apr 20, 2023, 4:05 PM EDT - 2 years ago

Seer to Report First Quarter 2023 Financial Results on May 9, 2023

Mar 29, 2023, 2:00 PM EDT - 2 years ago

Seer's Proteograph™ Product Suite identifies undiscovered links between protein variants and lung cancer progression

Mar 2, 2023, 10:32 PM EST - 2 years ago

Seer, Inc. (SEER) Q4 2022 Earnings Call Transcript

Mar 2, 2023, 4:05 PM EST - 2 years ago

Seer Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Outlook

Feb 21, 2023, 4:30 PM EST - 2 years ago

Seer to Present at the Cowen 43rd Annual Health Care Conference

Feb 9, 2023, 4:05 PM EST - 2 years ago

Seer to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023

Dec 27, 2022, 4:05 PM EST - 2 years ago

Seer to Present at the J.P. Morgan 41st Annual Health Care Conference

Dec 14, 2022, 8:00 AM EST - 2 years ago

DISCOVERY LIFE SCIENCES LAUNCHES WORLD-CLASS PROTEOMIC SERVICES DIVISION SUPPORTED BY LEADING TECHNOLOGY PARTNERS